Drug-Screen® Heroin Rapid Test

Description

Drug-Screen® Heroin Rapid Test

Rapid test for the detection of 6-monoacetylmorphine in urine – Cut-off: 10 ng/mL

6-Monoacetylmorphine (6-MAM) is a unique metabolite produced following the consumption of heroin. Usually smoked, snorted or injected intravenously, heroin is a fast-acting, semi-synthetic opioid which is both extremely potent and highly addictive. The famous rush it provides results from the dopamine-inducing effects it has on the brain and central nervous system, which evoke intense feelings of pleasure and
euphoria. First synthesized in 1874, heroin was initially marketed in the early 20th century for use as a morphine substitute and cough suppressant. Though sometimes used controversially in opioid replacement therapy, heroin remains an internationally controlled narcotic due to its high abuse potential. In addition to the euphoric effects it produces, heroin carries a number of risks and also provokes numerous undesirable and potentially fatal side effects. These mainly include shallow breathing and a weakened pulse. Intravenous use of heroin is also linked to an increased risk of contracting infectious diseases such as hepatitis B, C and HIV/AIDS, not to mention bacterial infections around the injection sites. With as many as 17.4 million opiate users worldwide (United Nations Office on Drugs and Crime, UNODC 2016 World Drug Report), heroin use, addiction and overdose all play significant roles on the drug scene. The spe- cific detection and prompt treatment of heroin abuse can mean the difference between life and death. However, commercially
available rapid tests for the detection of opiates do not allow a clear distinction between heroin use and the intake of
other opiates. To complement our Drug-Screen Morphine/Opiates test, nal von minden now offers the Drug-Screen Heroin urine rapid test for the fast and reliable detection of recent heroin use. The Drug-Screen Heroin (HRN) rapid test is a competitive immunoassay for the qualitative determination of the
heroin-specific metabolite 6-monoacetylmorphine in human urine, with a cut-off of 10 ng/mL. It can be used as an aid in the initiation or monitoring of therapeutic measures. As an in-vitro diagnostic tool for professional use, the test provides a visual and preliminary analytical result.
Your benefits at a glance:

✔ Detection window: 6-8 hours

✔ Easy to use

✔ Fast and reliable results in just 5 minutes

✔ Minimum 12 month shelf life

✔ In accordance with DIN EN ISO 15189 for medical laboratories, our rapid tests are available barcoded for use in reader-based evaluations

Drug-Screen® Heroin Rapid Test